uniQure Receives Additional $53M from Bristol-Myers Squibb for Target Selection Payment and Additional Equity Investment
August 10, 2015 at 05:03 AM EDT
uniQure N.V. (NASDAQ: QURE) today announced the receipt of an additional $53 million from Bristol-Myers Squibb (NYSE: BMY) in accordance ...
